Given tirzepatide's higher peak weight-loss efficacy, patients should expect some weight regain during the transition, typically 3 to 8%, in the first 12 weeks before semaglutide reaches its therapeutic dose
Epithalon is not approved for use by the United States Food and Drug Administration (FDA) and is not typically available by prescription in that country
for Wegovy, follow the specific guidance in the product labeling
Diarrhea typically appears within three to five days of starting or increasing your dose and peaks around day 710
It does mean patients should be careful about what is actually being prescribed, how thoroughly they are being evaluated, and whether there is a real follow-up plan
It is known that BDNF, an important neurotrophic factor, plays a crucial role in sustained antidepressant effect [46]